240 related articles for article (PubMed ID: 5354514)
1. [Therapy of polycythemia vera].
Stecher G; Hennemann HH
Minerva Med; 1969 Oct; 60(87):4351-3. PubMed ID: 5354514
[No Abstract] [Full Text] [Related]
2. [The therapy of polycythemia vera].
Hennemann HH; Stecher G
Dtsch Med Wochenschr; 1967 Oct; 92(41):1874-6. PubMed ID: 4383363
[No Abstract] [Full Text] [Related]
3. Treatment of polycythaemia vera.
Loeb V
Clin Haematol; 1975 Jun; 4(2):441-56. PubMed ID: 1102197
[No Abstract] [Full Text] [Related]
4. Management and therapy of polycythaemia vera.
Israëls MC
Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763
[No Abstract] [Full Text] [Related]
5. Pipobroman (Vercyte) - a new antineoplastic drug.
Med Lett Drugs Ther; 1967 Apr; 9(7):27. PubMed ID: 5298493
[No Abstract] [Full Text] [Related]
6. [Treatment of polycythemia vera].
Pribilla W
Dtsch Med J; 1968 Jun; 19(12):441-3. PubMed ID: 4891144
[No Abstract] [Full Text] [Related]
7. [Present treatment of the Vaquez's disease].
Vallée G; Boivin P; Dormont J; Soulier JP
Presse Med (1893); 1969 Mar; 77(14):517-9. PubMed ID: 5783371
[No Abstract] [Full Text] [Related]
8. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
Urasiński I; Mysik M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
[No Abstract] [Full Text] [Related]
9. Treatment of polycythaemia vera.
Watkins PJ; Fairley GH; Scott RB
Br Med J; 1967 Jun; 2(5553):664-6. PubMed ID: 6024523
[No Abstract] [Full Text] [Related]
10. Muramidase in polycythemia vera.
Binder RA; Gilbert HS
Blood; 1970 Aug; 36(2):228-32. PubMed ID: 5427457
[No Abstract] [Full Text] [Related]
11. [Iron metabolism in polycythemia vera].
Honetz N; Klotz H; Neumann E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):398-405. PubMed ID: 4107575
[No Abstract] [Full Text] [Related]
12. [I-131 absorption in patients with polycythemia vera and change in this index after treatment by bloodletting and with P32].
Shishkina VV; Suslina NG; Chebotareva ED
Med Radiol (Mosk); 1968 Apr; 13(4):50-4. PubMed ID: 5658003
[No Abstract] [Full Text] [Related]
13. [Current aspects of the treatment of polycythemia vera under polyclinical conditions].
Osechenskaia GV; Krasiukova LI
Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):21-4. PubMed ID: 628661
[No Abstract] [Full Text] [Related]
14. [The treatment of erythremia].
Demidova AV
Ter Arkh; 1992; 64(7):116-23. PubMed ID: 1440358
[No Abstract] [Full Text] [Related]
15. Platelet production rate in polycythemia vera after myelosuppressive therapy.
Kutti J
Acta Med Scand; 1972 Sep; 192(3):161-4. PubMed ID: 5055260
[No Abstract] [Full Text] [Related]
16. Natural history and management of polycythemia vera.
Hoffman R; Wasserman LR
Adv Intern Med; 1979; 24():255-85. PubMed ID: 371361
[No Abstract] [Full Text] [Related]
17. Blood and neoplastic diseases. Myeloproliferative disorders.
Lewis SM; Szur L
Br Med J; 1974 Nov; 4(5941):399-402. PubMed ID: 4425895
[No Abstract] [Full Text] [Related]
18. Treatment of polycythaemia vera.
Br Med J; 1966 Jul; 2(5507):186-7. PubMed ID: 5939091
[No Abstract] [Full Text] [Related]
19. Myelosuppression in polycythemia vera: chemotherapy or radiotherapy?
Najean Y; Dresch C
Blut; 1982 Jan; 44(1):1-5. PubMed ID: 7059686
[No Abstract] [Full Text] [Related]
20. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
Burger T; Schmelczer M; Molnár L; Pajor L; Koszorús S
Orv Hetil; 1987 Dec; 128(52):2723-30. PubMed ID: 3431872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
